Markers of instability in high-risk carotid plaques are reduced by statins

Background Macrophage infiltration and expression of matrix metalloproteinase-9 (MMP-9) are markers of high-risk atherosclerotic carotid plaques and strong indicators of plaque instability. Use of statins is associated with a decreased risk of stroke and reportedly improves stability of atherosclero...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of vascular surgery 2008-03, Vol.47 (3), p.513-522
Hauptverfasser: Kunte, Hagen, MD, Amberger, Nicola, MD, Busch, Markus Alexander, MD, MPH, Rückert, Ralph-Ingo, MD, PhD, Meiners, Silke, PhD, Harms, Lutz, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 522
container_issue 3
container_start_page 513
container_title Journal of vascular surgery
container_volume 47
creator Kunte, Hagen, MD
Amberger, Nicola, MD
Busch, Markus Alexander, MD, MPH
Rückert, Ralph-Ingo, MD, PhD
Meiners, Silke, PhD
Harms, Lutz, MD
description Background Macrophage infiltration and expression of matrix metalloproteinase-9 (MMP-9) are markers of high-risk atherosclerotic carotid plaques and strong indicators of plaque instability. Use of statins is associated with a decreased risk of stroke and reportedly improves stability of atherosclerotic plaques, but available data addressing the mechanism of this effect are conflicting. Methods We retrospectively analyzed data from 94 consecutive patients with internal carotid artery stenosis who underwent carotid endarterectomy. Excised plaques underwent systematic quantitative immunohistochemical analysis to determine the percentage of macrophage area and the percentage of MMP-9 area. Associations between percentage of macrophage area and percentage of MMP-9 area and use of statins and cerebrovascular disease were examined by univariate and multivariate analysis. Results We found significantly higher values of percentage of macrophage area and of MMP-9 area in recently symptomatic (n = 26) compared with asymptomatic (n = 68) internal carotid artery stenoses: median (IQR) percentage of macrophage area was 2.29 (1.53-4.129) vs 0.53 (0.27-0.96) and percentage of MMP-9 area was 0.61 (0.36-0.89) vs 0.08 (0.02-0.27; both P < .0005). Patients treated with statins (n = 49) showed lower percentage values of macrophage area and MMP-9 area than untreated patients: the percentage of macrophage area was 0.54 (0.31-1.18) vs 1.03 (0.57-2.08; P = .01) and percentage of MMP-9 area was 0.06 (0.02-0.22) vs 0.36 (0.16-0.62; P < .0005). These associations between statin treatment and percentages of macrophage area and MMP-9 area did not change after controlling for symptomatic cerebrovascular disease and the effects of other potential confounders in multivariable analysis. Conclusions Our results confirm the value of percentage of macrophage area and percentage of MMP-9 area as markers of plaque instability and provide further evidence to support the hypothesis that statins reduce inflammatory responses and thereby stabilize carotid atherosclerotic plaques.
doi_str_mv 10.1016/j.jvs.2007.11.045
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70330325</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0741521407018927</els_id><sourcerecordid>70330325</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-25f3dc2b9bb2c44949fc8cc3db41904ecd46ebf61c4b0ddae98fc0b9cb319cb43</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi0EotvCD-CCcoFbwoztbGIhIVUVFFARB-Bs-WNCnc0mi51U2n-Po12BxIHLeA7POx49w9gLhAoBt2_6qn9IFQdoKsQKZP2IbRBUU25bUI_ZBhqJZc1RXrDLlHoAxLptnrILbLmqEcSGff5i4o5iKqauCGOajQ1DmI-5L-7Dz_syhrQrnInTHHxxGMyvhVJhIhWR_OLIF_ZY5NScs8_Yk84MiZ6f3yv248P77zcfy7uvt59uru9KV8t6LnndCe-4VdZyJ6WSqnOtc8JbiQokOS-3ZLstOmnBe0Oq7RxY5azAXKS4Yq9Pcw9xWteZ9T4kR8NgRpqWpBsQAgSvM4gn0MUppUidPsSwN_GoEfQqUPc6C9SrQI2os8CceXkevtg9-b-Js7EMvDoDJjkzdNGMLqQ_HAcUDdTbzL09cZRVPASKOrlAY1YWIrlZ-yn8d413_6TdEMaQP9zRkVI_LXHMjjXqxDXob-ul10NDA9gq3ojfJtSjzA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70330325</pqid></control><display><type>article</type><title>Markers of instability in high-risk carotid plaques are reduced by statins</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Kunte, Hagen, MD ; Amberger, Nicola, MD ; Busch, Markus Alexander, MD, MPH ; Rückert, Ralph-Ingo, MD, PhD ; Meiners, Silke, PhD ; Harms, Lutz, MD</creator><creatorcontrib>Kunte, Hagen, MD ; Amberger, Nicola, MD ; Busch, Markus Alexander, MD, MPH ; Rückert, Ralph-Ingo, MD, PhD ; Meiners, Silke, PhD ; Harms, Lutz, MD</creatorcontrib><description>Background Macrophage infiltration and expression of matrix metalloproteinase-9 (MMP-9) are markers of high-risk atherosclerotic carotid plaques and strong indicators of plaque instability. Use of statins is associated with a decreased risk of stroke and reportedly improves stability of atherosclerotic plaques, but available data addressing the mechanism of this effect are conflicting. Methods We retrospectively analyzed data from 94 consecutive patients with internal carotid artery stenosis who underwent carotid endarterectomy. Excised plaques underwent systematic quantitative immunohistochemical analysis to determine the percentage of macrophage area and the percentage of MMP-9 area. Associations between percentage of macrophage area and percentage of MMP-9 area and use of statins and cerebrovascular disease were examined by univariate and multivariate analysis. Results We found significantly higher values of percentage of macrophage area and of MMP-9 area in recently symptomatic (n = 26) compared with asymptomatic (n = 68) internal carotid artery stenoses: median (IQR) percentage of macrophage area was 2.29 (1.53-4.129) vs 0.53 (0.27-0.96) and percentage of MMP-9 area was 0.61 (0.36-0.89) vs 0.08 (0.02-0.27; both P &lt; .0005). Patients treated with statins (n = 49) showed lower percentage values of macrophage area and MMP-9 area than untreated patients: the percentage of macrophage area was 0.54 (0.31-1.18) vs 1.03 (0.57-2.08; P = .01) and percentage of MMP-9 area was 0.06 (0.02-0.22) vs 0.36 (0.16-0.62; P &lt; .0005). These associations between statin treatment and percentages of macrophage area and MMP-9 area did not change after controlling for symptomatic cerebrovascular disease and the effects of other potential confounders in multivariable analysis. Conclusions Our results confirm the value of percentage of macrophage area and percentage of MMP-9 area as markers of plaque instability and provide further evidence to support the hypothesis that statins reduce inflammatory responses and thereby stabilize carotid atherosclerotic plaques.</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/j.jvs.2007.11.045</identifier><identifier>PMID: 18295103</identifier><identifier>CODEN: JVSUES</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Aged ; Anti-Inflammatory Agents - pharmacology ; Anti-Inflammatory Agents - therapeutic use ; Biological and medical sciences ; Biomarkers - analysis ; Carotid Artery, Internal - drug effects ; Carotid Artery, Internal - enzymology ; Carotid Artery, Internal - pathology ; Carotid Artery, Internal - surgery ; Carotid Stenosis - complications ; Carotid Stenosis - drug therapy ; Carotid Stenosis - enzymology ; Carotid Stenosis - pathology ; Carotid Stenosis - surgery ; Cerebrovascular Disorders - enzymology ; Cerebrovascular Disorders - etiology ; Cerebrovascular Disorders - pathology ; Cerebrovascular Disorders - prevention &amp; control ; Endarterectomy, Carotid ; Female ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use ; Immunohistochemistry ; Inflammation Mediators - analysis ; Macrophages - drug effects ; Macrophages - pathology ; Male ; Matrix Metalloproteinase 9 - analysis ; Medical sciences ; Middle Aged ; Neurology ; Odds Ratio ; Reproducibility of Results ; Retrospective Studies ; Risk Assessment ; Rupture ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Time Factors ; Vascular diseases and vascular malformations of the nervous system ; Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</subject><ispartof>Journal of vascular surgery, 2008-03, Vol.47 (3), p.513-522</ispartof><rights>The Society for Vascular Surgery</rights><rights>2008 The Society for Vascular Surgery</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-25f3dc2b9bb2c44949fc8cc3db41904ecd46ebf61c4b0ddae98fc0b9cb319cb43</citedby><cites>FETCH-LOGICAL-c545t-25f3dc2b9bb2c44949fc8cc3db41904ecd46ebf61c4b0ddae98fc0b9cb319cb43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jvs.2007.11.045$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,778,782,3539,27911,27912,45982</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20137056$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18295103$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kunte, Hagen, MD</creatorcontrib><creatorcontrib>Amberger, Nicola, MD</creatorcontrib><creatorcontrib>Busch, Markus Alexander, MD, MPH</creatorcontrib><creatorcontrib>Rückert, Ralph-Ingo, MD, PhD</creatorcontrib><creatorcontrib>Meiners, Silke, PhD</creatorcontrib><creatorcontrib>Harms, Lutz, MD</creatorcontrib><title>Markers of instability in high-risk carotid plaques are reduced by statins</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Background Macrophage infiltration and expression of matrix metalloproteinase-9 (MMP-9) are markers of high-risk atherosclerotic carotid plaques and strong indicators of plaque instability. Use of statins is associated with a decreased risk of stroke and reportedly improves stability of atherosclerotic plaques, but available data addressing the mechanism of this effect are conflicting. Methods We retrospectively analyzed data from 94 consecutive patients with internal carotid artery stenosis who underwent carotid endarterectomy. Excised plaques underwent systematic quantitative immunohistochemical analysis to determine the percentage of macrophage area and the percentage of MMP-9 area. Associations between percentage of macrophage area and percentage of MMP-9 area and use of statins and cerebrovascular disease were examined by univariate and multivariate analysis. Results We found significantly higher values of percentage of macrophage area and of MMP-9 area in recently symptomatic (n = 26) compared with asymptomatic (n = 68) internal carotid artery stenoses: median (IQR) percentage of macrophage area was 2.29 (1.53-4.129) vs 0.53 (0.27-0.96) and percentage of MMP-9 area was 0.61 (0.36-0.89) vs 0.08 (0.02-0.27; both P &lt; .0005). Patients treated with statins (n = 49) showed lower percentage values of macrophage area and MMP-9 area than untreated patients: the percentage of macrophage area was 0.54 (0.31-1.18) vs 1.03 (0.57-2.08; P = .01) and percentage of MMP-9 area was 0.06 (0.02-0.22) vs 0.36 (0.16-0.62; P &lt; .0005). These associations between statin treatment and percentages of macrophage area and MMP-9 area did not change after controlling for symptomatic cerebrovascular disease and the effects of other potential confounders in multivariable analysis. Conclusions Our results confirm the value of percentage of macrophage area and percentage of MMP-9 area as markers of plaque instability and provide further evidence to support the hypothesis that statins reduce inflammatory responses and thereby stabilize carotid atherosclerotic plaques.</description><subject>Aged</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - analysis</subject><subject>Carotid Artery, Internal - drug effects</subject><subject>Carotid Artery, Internal - enzymology</subject><subject>Carotid Artery, Internal - pathology</subject><subject>Carotid Artery, Internal - surgery</subject><subject>Carotid Stenosis - complications</subject><subject>Carotid Stenosis - drug therapy</subject><subject>Carotid Stenosis - enzymology</subject><subject>Carotid Stenosis - pathology</subject><subject>Carotid Stenosis - surgery</subject><subject>Cerebrovascular Disorders - enzymology</subject><subject>Cerebrovascular Disorders - etiology</subject><subject>Cerebrovascular Disorders - pathology</subject><subject>Cerebrovascular Disorders - prevention &amp; control</subject><subject>Endarterectomy, Carotid</subject><subject>Female</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</subject><subject>Immunohistochemistry</subject><subject>Inflammation Mediators - analysis</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - pathology</subject><subject>Male</subject><subject>Matrix Metalloproteinase 9 - analysis</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Odds Ratio</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Rupture</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Time Factors</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><subject>Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1v1DAQhi0EotvCD-CCcoFbwoztbGIhIVUVFFARB-Bs-WNCnc0mi51U2n-Po12BxIHLeA7POx49w9gLhAoBt2_6qn9IFQdoKsQKZP2IbRBUU25bUI_ZBhqJZc1RXrDLlHoAxLptnrILbLmqEcSGff5i4o5iKqauCGOajQ1DmI-5L-7Dz_syhrQrnInTHHxxGMyvhVJhIhWR_OLIF_ZY5NScs8_Yk84MiZ6f3yv248P77zcfy7uvt59uru9KV8t6LnndCe-4VdZyJ6WSqnOtc8JbiQokOS-3ZLstOmnBe0Oq7RxY5azAXKS4Yq9Pcw9xWteZ9T4kR8NgRpqWpBsQAgSvM4gn0MUppUidPsSwN_GoEfQqUPc6C9SrQI2os8CceXkevtg9-b-Js7EMvDoDJjkzdNGMLqQ_HAcUDdTbzL09cZRVPASKOrlAY1YWIrlZ-yn8d413_6TdEMaQP9zRkVI_LXHMjjXqxDXob-ul10NDA9gq3ojfJtSjzA</recordid><startdate>20080301</startdate><enddate>20080301</enddate><creator>Kunte, Hagen, MD</creator><creator>Amberger, Nicola, MD</creator><creator>Busch, Markus Alexander, MD, MPH</creator><creator>Rückert, Ralph-Ingo, MD, PhD</creator><creator>Meiners, Silke, PhD</creator><creator>Harms, Lutz, MD</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080301</creationdate><title>Markers of instability in high-risk carotid plaques are reduced by statins</title><author>Kunte, Hagen, MD ; Amberger, Nicola, MD ; Busch, Markus Alexander, MD, MPH ; Rückert, Ralph-Ingo, MD, PhD ; Meiners, Silke, PhD ; Harms, Lutz, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-25f3dc2b9bb2c44949fc8cc3db41904ecd46ebf61c4b0ddae98fc0b9cb319cb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Aged</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - analysis</topic><topic>Carotid Artery, Internal - drug effects</topic><topic>Carotid Artery, Internal - enzymology</topic><topic>Carotid Artery, Internal - pathology</topic><topic>Carotid Artery, Internal - surgery</topic><topic>Carotid Stenosis - complications</topic><topic>Carotid Stenosis - drug therapy</topic><topic>Carotid Stenosis - enzymology</topic><topic>Carotid Stenosis - pathology</topic><topic>Carotid Stenosis - surgery</topic><topic>Cerebrovascular Disorders - enzymology</topic><topic>Cerebrovascular Disorders - etiology</topic><topic>Cerebrovascular Disorders - pathology</topic><topic>Cerebrovascular Disorders - prevention &amp; control</topic><topic>Endarterectomy, Carotid</topic><topic>Female</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</topic><topic>Immunohistochemistry</topic><topic>Inflammation Mediators - analysis</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - pathology</topic><topic>Male</topic><topic>Matrix Metalloproteinase 9 - analysis</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Odds Ratio</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Rupture</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Time Factors</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><topic>Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kunte, Hagen, MD</creatorcontrib><creatorcontrib>Amberger, Nicola, MD</creatorcontrib><creatorcontrib>Busch, Markus Alexander, MD, MPH</creatorcontrib><creatorcontrib>Rückert, Ralph-Ingo, MD, PhD</creatorcontrib><creatorcontrib>Meiners, Silke, PhD</creatorcontrib><creatorcontrib>Harms, Lutz, MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kunte, Hagen, MD</au><au>Amberger, Nicola, MD</au><au>Busch, Markus Alexander, MD, MPH</au><au>Rückert, Ralph-Ingo, MD, PhD</au><au>Meiners, Silke, PhD</au><au>Harms, Lutz, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Markers of instability in high-risk carotid plaques are reduced by statins</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>2008-03-01</date><risdate>2008</risdate><volume>47</volume><issue>3</issue><spage>513</spage><epage>522</epage><pages>513-522</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><coden>JVSUES</coden><abstract>Background Macrophage infiltration and expression of matrix metalloproteinase-9 (MMP-9) are markers of high-risk atherosclerotic carotid plaques and strong indicators of plaque instability. Use of statins is associated with a decreased risk of stroke and reportedly improves stability of atherosclerotic plaques, but available data addressing the mechanism of this effect are conflicting. Methods We retrospectively analyzed data from 94 consecutive patients with internal carotid artery stenosis who underwent carotid endarterectomy. Excised plaques underwent systematic quantitative immunohistochemical analysis to determine the percentage of macrophage area and the percentage of MMP-9 area. Associations between percentage of macrophage area and percentage of MMP-9 area and use of statins and cerebrovascular disease were examined by univariate and multivariate analysis. Results We found significantly higher values of percentage of macrophage area and of MMP-9 area in recently symptomatic (n = 26) compared with asymptomatic (n = 68) internal carotid artery stenoses: median (IQR) percentage of macrophage area was 2.29 (1.53-4.129) vs 0.53 (0.27-0.96) and percentage of MMP-9 area was 0.61 (0.36-0.89) vs 0.08 (0.02-0.27; both P &lt; .0005). Patients treated with statins (n = 49) showed lower percentage values of macrophage area and MMP-9 area than untreated patients: the percentage of macrophage area was 0.54 (0.31-1.18) vs 1.03 (0.57-2.08; P = .01) and percentage of MMP-9 area was 0.06 (0.02-0.22) vs 0.36 (0.16-0.62; P &lt; .0005). These associations between statin treatment and percentages of macrophage area and MMP-9 area did not change after controlling for symptomatic cerebrovascular disease and the effects of other potential confounders in multivariable analysis. Conclusions Our results confirm the value of percentage of macrophage area and percentage of MMP-9 area as markers of plaque instability and provide further evidence to support the hypothesis that statins reduce inflammatory responses and thereby stabilize carotid atherosclerotic plaques.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>18295103</pmid><doi>10.1016/j.jvs.2007.11.045</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-5214
ispartof Journal of vascular surgery, 2008-03, Vol.47 (3), p.513-522
issn 0741-5214
1097-6809
language eng
recordid cdi_proquest_miscellaneous_70330325
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ScienceDirect Journals (5 years ago - present)
subjects Aged
Anti-Inflammatory Agents - pharmacology
Anti-Inflammatory Agents - therapeutic use
Biological and medical sciences
Biomarkers - analysis
Carotid Artery, Internal - drug effects
Carotid Artery, Internal - enzymology
Carotid Artery, Internal - pathology
Carotid Artery, Internal - surgery
Carotid Stenosis - complications
Carotid Stenosis - drug therapy
Carotid Stenosis - enzymology
Carotid Stenosis - pathology
Carotid Stenosis - surgery
Cerebrovascular Disorders - enzymology
Cerebrovascular Disorders - etiology
Cerebrovascular Disorders - pathology
Cerebrovascular Disorders - prevention & control
Endarterectomy, Carotid
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Immunohistochemistry
Inflammation Mediators - analysis
Macrophages - drug effects
Macrophages - pathology
Male
Matrix Metalloproteinase 9 - analysis
Medical sciences
Middle Aged
Neurology
Odds Ratio
Reproducibility of Results
Retrospective Studies
Risk Assessment
Rupture
Surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Time Factors
Vascular diseases and vascular malformations of the nervous system
Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels
title Markers of instability in high-risk carotid plaques are reduced by statins
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T19%3A52%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Markers%20of%20instability%20in%20high-risk%20carotid%20plaques%20are%20reduced%20by%20statins&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Kunte,%20Hagen,%20MD&rft.date=2008-03-01&rft.volume=47&rft.issue=3&rft.spage=513&rft.epage=522&rft.pages=513-522&rft.issn=0741-5214&rft.eissn=1097-6809&rft.coden=JVSUES&rft_id=info:doi/10.1016/j.jvs.2007.11.045&rft_dat=%3Cproquest_cross%3E70330325%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70330325&rft_id=info:pmid/18295103&rft_els_id=S0741521407018927&rfr_iscdi=true